SignalPath Revenue and Competitors

Location

$34.5M

Total Funding

Estimated Revenue & Valuation

  • SignalPath's estimated annual revenue is currently $1.6M per year.(i)
  • SignalPath's estimated revenue per employee is $72,500
  • SignalPath's total funding is $34.5M.

Employee Data

  • SignalPath has 22 Employees.(i)
  • SignalPath grew their employee count by -12% last year.

SignalPath's People

NameTitleEmail/Phone
1
Co-Founder and Board MemberReveal Email/Phone
2
SVP Sponsor and CRO SolutionsReveal Email/Phone
3
VP DigitizationReveal Email/Phone
4
Director DigitizationReveal Email/Phone
5
Director EngineeringReveal Email/Phone
6
Director Business DevelopmentReveal Email/Phone
7
Compliance ManagerReveal Email/Phone
8
Sr. Client Engagement ManagerReveal Email/Phone
9
Administrative & HR Services ManagerReveal Email/Phone
10
Manager Software Quality AssuranceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.4M6N/AN/AN/A
#2
$1.7M190%N/AN/A
#3
$11.2M7754%N/AN/A
#4
$0.6M8-20%N/AN/A
#5
$0.4M6N/AN/AN/A
#6
$2M20-9%N/AN/A
#7
$0.9M100%N/AN/A
#8
$0.9M10-29%N/AN/A
#9
$0.7M9-10%N/AN/A
#10
$5.1M442%N/AN/A
Add Company

What Is SignalPath?

SignalPath is designing the next generation of software for clinical research sites and those managing networks of sites. Our mission is to enhance clinical research by dramatically improving the ease and efficiency of trial execution.

keywords:saas

$34.5M

Total Funding

22

Number of Employees

$1.6M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SignalPath News

2021-08-17 - Verily Acquires Clinical Trials Management Platform SignalPath, Marks First Acquisition

What You Should Know: Verily, an Alphabet company announced an agreement to acquire SignalPath, a Raleigh, NC-based clinical trial management system (CTMS) that improves the ease, quality and efficiency of conducting clinical research at study sites. Financial details of the acquisition were no ...

2021-02-23 - Quantum Leap and SignalPath Partner to Integrate Clinical Trial Software Infrastructure Across I-SPY Platform Trials

SAN FRANCISCO, CA & RALEIGH, NC--(BUSINESS WIRE)--Feb 23, 2021-- Quantum Leap Healthcare Cooperative (Quantum Leap) and SignalPath announced a partnership today that will further empower the I-SPY platform trials with robust, streamlined technology infrastructure to drive the ease and efficienc ...

2019-10-22 - SignalPath Closes $18M Series B Funding

SignalPath, a Raleigh, NC-based clinical trial technology startup, closed a $18M Series B funding round. The round brought total funding raised to date to $35M. The company intends to use the funds to grow the research teams and products. Led by Dr. Brad Hirsch, Co-Founder & CEO, SignalPath i ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.2M225%N/A
#2
$2.2M220%N/A
#3
$2.2M220%N/A
#4
$3.8M22N/AN/A
#5
$1.6M22-41%$34.5M